Company Monitoring Page for Amarin

job ratings for Amarin

08/02/21
industry:
pharmaceutical
job title:
Sales
company:
Amarin
job rating:
4
Not paying well enough

latest headlines for company on cafepharma

Amarin's CEO resigns, leaving former interim chief to take over struggling drugmaker
Fierce Pharma
Tue, 06/4/24 - 11:50 am
Tags:
Amarin, Pharma CEOs, Patrick Holt, Aaron Berg
Amarin axes 120 of its 385 employees, hires new CEO Patrick Holt
Fierce Pharma
Wed, 07/19/23 - 11:48 am
Tags:
Amarin, layoffs, restructuring, Patrick Holt
Amarin’s feud with Sarissa Capital leads to CEO Karum Mikhail’s abrupt departure
Medical Devices and Diagnostics Industry
Sun, 04/2/23 - 04:24 pm
Tags:
Amarin, Sarissa, Karum Mikhail
Alex Denner's firm takes over Amarin, ousts non-Sarissa board members
Endpoints
Tue, 03/7/23 - 11:22 am
Tags:
Amarin, Sarissa Capital, Alex Denner
Amarin Posts New Data Showing Benefit of Vascepa In High-Risk Patients With Acute Coronary Syndrome
Yahoo/Benzinga
Tue, 03/7/23 - 10:16 am
Tags:
Amarin, Vascepa, Vazkepa, acute coronary syndrome, clinical trials
In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics
Fierce Pharma
Fri, 02/24/23 - 08:55 am
Tags:
Amarin, Hikma, legal, antitrust, generics, Vascepa
Struggling Amarin jousts with activist investor Sarissa as board vote nears
Fierce Pharma
Tue, 02/14/23 - 10:44 am
Tags:
Amarin, Vascepa, investors
Why Amarin Stock Tumbled This Week
Motley Fool
Fri, 01/20/23 - 10:20 am
Tags:
Amarin
Why Amarin Stock Was a Winner Today
Motley Fool
Tue, 11/15/22 - 06:38 pm
Tags:
Amarin, Australia, Vazkepa, Vascepa
Amarin stands behind Vascepa after new analysis raises questions about its efficacy
Fierce Pharma
Tue, 07/5/22 - 12:04 am
Tags:
Amarin, Vascepa
Amarin turns to job cuts as generics challenge its heart pill
BioPharma Dive
Tue, 06/7/22 - 10:18 am
Tags:
Amarin, Vascepa, restructuring, layoffs
Amarin CFO resigns amid cost-cutting measures, staff reduction of 40%
Endpoints
Mon, 06/6/22 - 11:38 pm
Tags:
Amarin, restructuring, layoffs
Amarin, after 33% revenue decline, aims to 'stabilize' US sales and grow in Europe
Fierce Pharma
Thu, 05/5/22 - 10:21 am
Tags:
Amarin, earnings
With sales sagging, Amarin sees progress on new Vascepa digital effort in the US
Fierce Pharma
Wed, 03/2/22 - 09:55 am
Tags:
Amarin, Vascepa, digital marketing, digital pharma
End-of-Year Restructuring Means Layoffs for These Companies
BioSpace
Tue, 11/16/21 - 11:57 am
Tags:
restructuring, Rigel Pharmaceuticals, Zymergen, Esperion Therapeutics, Amarin, Theravance, Sanofi, Acorda Therapeutics, CureVac, Ziopharm Oncology
Faced with generic rivals, Amarin cuts 400-plus sales reps as part of revamped Vascepa strategy
Fierce Pharma
Thu, 09/23/21 - 10:29 pm
Tags:
Amarin, Vascepa, layoffs, generics
ESC: Amarin touts Vascepa's ability to reduce repeat heart problems as it fights generic with 'skinny label' claim
Fierce Pharma
Mon, 08/23/21 - 11:32 pm
Tags:
Amarin, Vascepa, Hikma
Amarin's Vascepa patent defense ends in a loss at the Supreme Court
Fierce Pharma
Mon, 06/21/21 - 10:09 pm
Tags:
Amarin, Vascepa, Supreme Court, patents
Amarin CEO Thero to Retire as Company Pivots Focus to Global Markets
BioSpace
Tue, 04/13/21 - 10:09 pm
Tags:
Amarin, Pharma CEOs, John Thero, Vaskepa, Europe
Amarin launches Vascepa in all-important Europe as it slowly bleeds share to U.S. generic
Fierce Pharma
Tue, 04/6/21 - 11:02 pm
Tags:
Amarin, Vascepa, Europe, Vazkepa

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.